TissGeneSummary for MFSD12 |
Gene summary |
Basic gene information | Gene symbol | MFSD12 |
Gene name | major facilitator superfamily domain containing 12 | |
Synonyms | C19orf28|PP3501 | |
Cytomap | UCSC genome browser: 19p13.3 | |
Type of gene | protein-coding | |
RefGenes | NM_001042680.1, NM_021731.2,NM_001287529.1,NM_174983.4, | |
Description | major facilitator superfamily domain-containing protein 12 | |
Modification date | 20141207 | |
dbXrefs | HGNC : HGNC | |
Ensembl : ENSG00000161091 | ||
HPRD : 12704 | ||
Vega : OTTHUMG00000180766 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_MFSD12 | |
BioGPS: 126321 | ||
Pathway | NCI Pathway Interaction Database: MFSD12 | |
KEGG: MFSD12 | ||
REACTOME: MFSD12 | ||
Pathway Commons: MFSD12 | ||
Context | iHOP: MFSD12 | |
ligand binding site mutation search in PubMed: MFSD12 | ||
UCL Cancer Institute: MFSD12 | ||
Assigned class in TissGDB* | C | |
Included tissue-specific gene expression resources | TiGER,GTEx | |
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | KidneySkin | |
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | KIRC,KIRP,KICHSKCM | |
Reference showing the relevant tissue of MFSD12 | ||
Description by TissGene annotations | Fused withTSGene |
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO term | PubMed ID |
Top |
TissGeneExp for MFSD12 |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
Top |
TissGene-miRNA for MFSD12 |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
Top |
TissGeneMut for MFSD12 |
TissGeneSNV for MFSD12 |
nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
- nsSNVs sorted by frequency. |
AAchange | Cancer type | # samples |
p.K332R | SKCM | 1 |
p.T254S | GBM | 1 |
p.S55F | SKCM | 1 |
p.E165Q | BLCA | 1 |
p.M331I | SKCM | 1 |
p.A229T | STAD | 1 |
p.M408I | LUAD | 1 |
p.E162K | HNSC | 1 |
p.W535C | PRAD | 1 |
p.E248K | SKCM | 1 |
p.R472G | LIHC | 1 |
p.D534H | HNSC | 1 |
p.Y301H | UCEC | 1 |
p.M446L | KIRC | 1 |
p.P3Q | THYM | 1 |
p.G59E | GBM | 1 |
p.Y131C | BLCA | 1 |
p.S491T | KIRC | 1 |
p.G238D | PAAD | 1 |
p.T254N | BLCA | 1 |
p.C115G | SKCM | 1 |
p.A127V | COAD | 1 |
p.H443N | ESCA | 1 |
p.A121S | LUAD | 1 |
p.V224L | SKCM | 1 |
p.T167M | GBM | 1 |
p.A361V | UCEC | 1 |
p.S327Y | ESCA | 1 |
p.L459M | SKCM | 1 |
p.R472X | STAD | 1 |
p.R243H | COAD | 1 |
p.P255L | SKCM | 1 |
p.A120T | LUAD | 1 |
p.F108S | COAD | 1 |
p.G417R | SKCM | 1 |
p.W357C | STAD | 1 |
p.V453M | SKCM | 1 |
p.S49W | CESC | 1 |
p.T167M | BLCA | 1 |
p.G395S | DLBC | 1 |
p.S107F | PRAD | 1 |
Top |
TissGeneCNV for MFSD12 |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
Top |
TissGeneFusions for MFSD12 |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
Chimerdb3.0 | ChiTaRs | NA | BG951551 | CHURC1-MFSD12 | chr14:65406444 | chr19:3556625 | |
Chimerdb3.0 | ChiTaRs | NA | CB529014 | MFSD12-MFSD12 | chr19:3544555 | chr19:3544894 | |
Chimerdb3.0 | FusionScan | BRCA | TCGA-E9-A1NA-01A | MFSD12-PIP5K1C | Out-of-Frame | chr19:3557103 | chr19:3646056 |
Chimerdb3.0 | FusionScan | BRCA | TCGA-C8-A12L-01A | RPL36-MFSD12 | 5'UTR-CDS | chr19:5690338 | chr19:3544937 |
Chimerdb3.0 | TopHat-Fusion | BRCA | TCGA-C8-A12L-01A | FZR1-MFSD12 | Out-of-Frame | chr19:3524189 | chr19:3545107 |
Chimerdb3.0 | TopHat-Fusion | BRCA | TCGA-C8-A12L-01A | FZR1-MFSD12 | Out-of-Frame | chr19:3524571 | chr19:3544936 |
Top |
TissGeneNet for MFSD12 |
Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
Top |
TissGeneProg for MFSD12 |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Top |
TissGeneClin for MFSD12 |
TissGeneDrug for MFSD12 |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
TissGeneDisease for MFSD12 |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
Disease ID | Disease name | # pubmeds | Source |
umls:C0027819 | Neuroblastoma | 1 | BeFree |
umls:C0700095 | Central neuroblastoma | 1 | BeFree |